Ecstasy induced acute hepatic failure. Case reports

3,4-methylenedioxymethamphetamine (MDMA), an amphet- amine derivative known as ecstasy, has stimulating and hallucino- genic properties. It has become a substance that is widely used es- pecially by young people. Hepatotoxicity is one of the rare side effects of this substance and can be fatal. Ecstasy-induced fulmi- nant hepatitis has been reported in case reports. The clinical course and the prognosis of the cases may differ. In this article, two cases in whom ecstasy-induced fulminant hepatic failure had developed and who were treated with liver transplantation, and one case which recovered with treatment, have been presented. (Acta gastro- enterol. belg., 2015, 78, 53-55).